Stefania Montero
Stefania Montero has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Luis Morales Ojeda
University of Colorado Anschutz Medical Center
6 shared publications Anibal La Riva
Department of Urology
3 shared publicationsDonald L. Jacobs
3 shared publicationsPriya Kohli
Department of Urology
3 shared publications- Rafael Demarchi Malgor
Division of Vascular and Endovascular Surgery, University of Colorado, Anschutz Medical Center, Aurora, CO
3 shared publications Aidin Abedi
Department of Urology
2 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Elsevier in EJVES Vascular Forum
Comparative Outcomes of Thoracoabdominal Aortic Aneurysms Treated with Physician Modified Endografts in Elective, Urgent, and Emergency Settings
- 16 November 2026
- Published by Elsevier in EJVES Vascular Forum
Open AccessComparative Outcomes of Thoracoabdominal Aortic Aneurysms Treated with Physician Modified Endografts in Elective, Urgent, and Emergency Settings
- 9 February 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (2) , e35-e36
The value of vascular surgeons in modern health care systems: A systematic review and meta-analysis
- 9 February 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (2) , e35-e36
The value of vascular surgeons in modern health care systems: A systematic review and meta-analysis
- 29 October 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (3) , 933-951
The value of vascular surgeons in modern health care systems: A systematic review and meta-analysis
- 29 October 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (3) , 933-951
The value of vascular surgeons in modern health care systems: A systematic review and meta-analysis
- Open Access
- 26 June 2025
- Published by SAGE Publications in The American Surgeon™
- Vol. 91 (10) , 1749-1753
Less is More: A Cost and Environmental Waste Analysis in Nonadherence to Antibiotic Prophylaxis Guidelines in Clean Ambulatory Surgical Procedures
Background: Antibiotic misuse extends beyond clinical outcomes, imposing significant financial, operational, and environmental burdens on health care systems. Despite guidelines advising against antibiotic prophylaxis for elective low-risk laparoscopic operations, clean head and neck, and soft tissue procedures, many surgeons continue to use them. We performed a cost and environmental waste analysis at our institution resulting from nonadherence to guidelines. Methods: A retrospective chart review was performed at a single institution between January 2022 and March 2023. All patients undergoing elective diagnostic laparoscopy, soft tissue excisions for presumed benign disease, thyroid, and parathyroidectomy operations were included. Antibiotic costs were obtained from the hospital charge pharmacy. Waste was estimated by weighing the bottles and syringes used to administer the antibiotics. Results: From January 2022 to March 2023, 137 patients who underwent the defined operations were identified. 38% (n = 52) underwent lipoma excisions, 33% (n = 46) thyroidectomy, 11% (n = 15) parathyroidectomy, 9% (n = 12) diagnostic laparoscopy, and 9% (n = 12) other soft tissue excision. 94% (n = 129) of cases were classified as clean and 6% (n = 8) were classified as clean-contaminated in the operative report. Prophylactic antibiotics were administered to 92% (n = 126) of patients, with 6% (n = 8) receiving an additional intraoperative dose. Cefazolin was used in 90% (n = 119) of cases, followed by Cefoxitin 1% (n = 1) and Clindamycin 1% (n = 1). Adherence to guidelines could have saved US$3279 and prevented £23 of waste. Discussion: A significant number of clean cases received prophylactic antibiotics, reflecting poor adherence to clinical practice guidelines. Improving antibiotic stewardship can reduce costs and environmental waste.
- 26 June 2025
- Published by SAGE Publications in The American Surgeon™
- Vol. 91 (10) , 1749-1753
Open AccessLess is More: A Cost and Environmental Waste Analysis in Nonadherence to Antibiotic Prophylaxis Guidelines in Clean Ambulatory Surgical Procedures
Background: Antibiotic misuse extends beyond clinical outcomes, imposing significant financial, operational, and environmental burdens on health care systems. Despite guidelines advising against antibiotic prophylaxis for elective low-risk laparoscopic operations, clean head and neck, and soft tissue procedures, many surgeons continue to use them. We performed a cost and environmental waste analysis at our institution resulting from nonadherence to guidelines. Methods: A retrospective chart review was performed at a single institution between January 2022 and March 2023. All patients undergoing elective diagnostic laparoscopy, soft tissue excisions for presumed benign disease, thyroid, and parathyroidectomy operations were included. Antibiotic costs were obtained from the hospital charge pharmacy. Waste was estimated by weighing the bottles and syringes used to administer the antibiotics. Results: From January 2022 to March 2023, 137 patients who underwent the defined operations were identified. 38% (n = 52) underwent lipoma excisions, 33% (n = 46) thyroidectomy, 11% (n = 15) parathyroidectomy, 9% (n = 12) diagnostic laparoscopy, and 9% (n = 12) other soft tissue excision. 94% (n = 129) of cases were classified as clean and 6% (n = 8) were classified as clean-contaminated in the operative report. Prophylactic antibiotics were administered to 92% (n = 126) of patients, with 6% (n = 8) receiving an additional intraoperative dose. Cefazolin was used in 90% (n = 119) of cases, followed by Cefoxitin 1% (n = 1) and Clindamycin 1% (n = 1). Adherence to guidelines could have saved US$3279 and prevented £23 of waste. Discussion: A significant number of clean cases received prophylactic antibiotics, reflecting poor adherence to clinical practice guidelines. Improving antibiotic stewardship can reduce costs and environmental waste.
- Open Access
- 19 April 2024
- Published by SAGE Publications in The American Surgeon™
- Vol. 90 (10) , 2419-2423
Poor Acceptance of the Revised Classification of Premalignant Anal Lesions Following the LAST Standardized Project
Introduction: The Lower Anogenital Squamous Terminology (LAST) Project recommended unified classification for HPV–associated squamous lesions of the lower anogenital tract, using a 2-tiered nomenclature in 2013. Adherence to the new nomenclature worldwide is unknown. This study aims to assess the trend of the use of the two-tiered High Squamous Intraepithelial Lesion and Low Squamous Intraepithelial Lesion (HSIL/LSIL) as opposed to the traditional three-tiered Anal Intraepithelial Neoplasia (AIN I/II/III) classification as suggested by the LAST Project. Methods: A literature search on full-text English language studies of premalignant anal lesion was performed on PubMed from 2002-2022. The studies were categorized by continent, and the prevalence of HSIL/LSIL classification vs AIN I/II/III was calculated. Results: 546 studies and 251 studies were identified using the AIN I/II/II and the HSIL/LSIL classification respectively. Global trend suggested a statistically significant downward trend in the use of the two-tiered nomenclature system in publications globally. Regional trend including North America, Europe, and other (Asia and Latin America) showed variance in adoption of the two-tiered nomenclature system. Conclusion: Despite multidisciplinary collaborative effort, adherence to the recommendations to use the two-tiered system for HPV-associated premalignant anal lesions continues to be suboptimal. Further efforts are needed to identify the cause of poor adherence to be able to create strategies that reinforces unification of terminology and integration of LAST the recommendations.
- 19 April 2024
- Published by SAGE Publications in The American Surgeon™
- Vol. 90 (10) , 2419-2423
Open AccessPoor Acceptance of the Revised Classification of Premalignant Anal Lesions Following the LAST Standardized Project
Introduction: The Lower Anogenital Squamous Terminology (LAST) Project recommended unified classification for HPV–associated squamous lesions of the lower anogenital tract, using a 2-tiered nomenclature in 2013. Adherence to the new nomenclature worldwide is unknown. This study aims to assess the trend of the use of the two-tiered High Squamous Intraepithelial Lesion and Low Squamous Intraepithelial Lesion (HSIL/LSIL) as opposed to the traditional three-tiered Anal Intraepithelial Neoplasia (AIN I/II/III) classification as suggested by the LAST Project. Methods: A literature search on full-text English language studies of premalignant anal lesion was performed on PubMed from 2002-2022. The studies were categorized by continent, and the prevalence of HSIL/LSIL classification vs AIN I/II/III was calculated. Results: 546 studies and 251 studies were identified using the AIN I/II/II and the HSIL/LSIL classification respectively. Global trend suggested a statistically significant downward trend in the use of the two-tiered nomenclature system in publications globally. Regional trend including North America, Europe, and other (Asia and Latin America) showed variance in adoption of the two-tiered nomenclature system. Conclusion: Despite multidisciplinary collaborative effort, adherence to the recommendations to use the two-tiered system for HPV-associated premalignant anal lesions continues to be suboptimal. Further efforts are needed to identify the cause of poor adherence to be able to create strategies that reinforces unification of terminology and integration of LAST the recommendations.
- 1 February 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 211 (2) , 304
Reply by Authors
- 1 February 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 211 (2) , 304
Reply by Authors
- 1 February 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 211 (2) , 294-304
A Pilot Study of the Effect of Transcutaneous Spinal Cord Stimulation on Micturition-Related Brain Activity and Lower Urinary Tract Symptoms After Stroke
Transcutaneous spinal cord stimulation (TSCS) is a novel neuromodulation modality developed to promote functional restoration in patients with neurological injury or disease. Previous pilot data suggest that lower urinary tract dysfunction (LUTD) due to stroke may be partially alleviated by TSCS. In this study, we examine the mechanism of this effect by evaluating bladder-related brain activity in patients before and after TSCS therapy and comparing it to healthy volunteers. Patients who developed storage LUTD after a stroke and healthy volunteers without LUTD were recruited. Patients and healthy volunteers underwent simultaneous urodynamics (UDS) and functional magnetic resonance imaging (fMRI). Patients then completed 24 biweekly sessions of TSCS and underwent another simultaneous UDS-fMRI study. Clinical outcomes were assessed using validated questionnaires and voiding diary. Fifteen patients and 16 healthy volunteers completed the study. Following TSCS, patients exhibited increased blood-oxygen-level dependent (BOLD) activity in areas including periaqueductal grey, the insula, the lateral prefrontal cortex, and motor cortex. Prior to TSCS therapy, healthy controls exhibited higher BOLD activity in 17 regions, including multiple regions in the prefrontal cortex and basal ganglia. These differences were attenuated after TSCS with no frontal brain differences remaining between healthy volunteers and stroke participants who completed therapy. Neuroimaging changes were complemented by clinically significant improvements in questionnaire scores and voiding diary parameters. TSCS therapy modulated bladder-related brain activity, reducing differences between healthy volunteers and stroke patients with LUTD. These changes, alongside improved clinical outcomes, suggest TSCS as a promising approach for LUTD management.
- 1 February 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 211 (2) , 294-304
A Pilot Study of the Effect of Transcutaneous Spinal Cord Stimulation on Micturition-Related Brain Activity and Lower Urinary Tract Symptoms After Stroke
Transcutaneous spinal cord stimulation (TSCS) is a novel neuromodulation modality developed to promote functional restoration in patients with neurological injury or disease. Previous pilot data suggest that lower urinary tract dysfunction (LUTD) due to stroke may be partially alleviated by TSCS. In this study, we examine the mechanism of this effect by evaluating bladder-related brain activity in patients before and after TSCS therapy and comparing it to healthy volunteers. Patients who developed storage LUTD after a stroke and healthy volunteers without LUTD were recruited. Patients and healthy volunteers underwent simultaneous urodynamics (UDS) and functional magnetic resonance imaging (fMRI). Patients then completed 24 biweekly sessions of TSCS and underwent another simultaneous UDS-fMRI study. Clinical outcomes were assessed using validated questionnaires and voiding diary. Fifteen patients and 16 healthy volunteers completed the study. Following TSCS, patients exhibited increased blood-oxygen-level dependent (BOLD) activity in areas including periaqueductal grey, the insula, the lateral prefrontal cortex, and motor cortex. Prior to TSCS therapy, healthy controls exhibited higher BOLD activity in 17 regions, including multiple regions in the prefrontal cortex and basal ganglia. These differences were attenuated after TSCS with no frontal brain differences remaining between healthy volunteers and stroke participants who completed therapy. Neuroimaging changes were complemented by clinically significant improvements in questionnaire scores and voiding diary parameters. TSCS therapy modulated bladder-related brain activity, reducing differences between healthy volunteers and stroke patients with LUTD. These changes, alongside improved clinical outcomes, suggest TSCS as a promising approach for LUTD management.
- 30 November 2023
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 40 (23-24) , 2648-2653
Resilience as an Independent Predictor of Bowel Related Quality of Life After Spinal Cord Injury
Bowel dysfunction remains a prominent priority in the rehabilitation of patients with spinal cord injuries (SCIs). However, our understanding of the factors that influence bowel-related quality of life (QoL) in this population remains limited. This study aimed to investigate the potential role of resilience, defined as an individual's capacity to cope with and adapt to adversity, as a predictor of bowel-related QoL among the patients with SCI. A cohort of adult patients with SCI who received bowel and bladder care at an outpatient clinic within a large rehabilitation hospital was identified through a prospectively collected database. Resilience was measured using the Spinal Cord Injury-Quality of Life (SCI-QOL) Resilience Short Form, whereas bowel QoL was assessed using the Irritable Bowel Syndrome-Quality of Life (IBS-QoL) questionnaire. Univariate and multivariate regression analyses were employed to identify predictors of bowel-related QoL. The examined variables included age, gender, level and completeness of injury, time since injury, hand function, resilience, and the severity of bowel dysfunction as measured using the Neurogenic Bowel Dysfunction Score (NBDS). A total of 73 patients participated in this study, with a mean age of 44.01 ± 13.43 years and comprising mostly men ( n = 57, 78%). The results revealed a significant correlation between resilience scores and the total score of IBS-QoL ( ρ = -0.47, p < 0.0001). The multivariate analysis demonstrated that both resilience and the severity of bowel dysfunction were significant independent predictors of bowel-related QoL, with resilience demonstrating a stronger association. Overall, this study elucidates the importance of resilience in shaping patients' perceptions of their bowel health within the SCI population. In addition to the more expected determinants of bowel-related QoL, such as the severity of bowel dysfunction, resilience emerged as a notable factor. Accordingly, integrating interventions that enhance resilience within bowel rehabilitation programs may yield improvements in patients' perceived bowel health beyond the benefits achievable through bowel function enhancement alone.
- 30 November 2023
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 40 (23-24) , 2648-2653
Resilience as an Independent Predictor of Bowel Related Quality of Life After Spinal Cord Injury
Bowel dysfunction remains a prominent priority in the rehabilitation of patients with spinal cord injuries (SCIs). However, our understanding of the factors that influence bowel-related quality of life (QoL) in this population remains limited. This study aimed to investigate the potential role of resilience, defined as an individual's capacity to cope with and adapt to adversity, as a predictor of bowel-related QoL among the patients with SCI. A cohort of adult patients with SCI who received bowel and bladder care at an outpatient clinic within a large rehabilitation hospital was identified through a prospectively collected database. Resilience was measured using the Spinal Cord Injury-Quality of Life (SCI-QOL) Resilience Short Form, whereas bowel QoL was assessed using the Irritable Bowel Syndrome-Quality of Life (IBS-QoL) questionnaire. Univariate and multivariate regression analyses were employed to identify predictors of bowel-related QoL. The examined variables included age, gender, level and completeness of injury, time since injury, hand function, resilience, and the severity of bowel dysfunction as measured using the Neurogenic Bowel Dysfunction Score (NBDS). A total of 73 patients participated in this study, with a mean age of 44.01 ± 13.43 years and comprising mostly men ( n = 57, 78%). The results revealed a significant correlation between resilience scores and the total score of IBS-QoL ( ρ = -0.47, p < 0.0001). The multivariate analysis demonstrated that both resilience and the severity of bowel dysfunction were significant independent predictors of bowel-related QoL, with resilience demonstrating a stronger association. Overall, this study elucidates the importance of resilience in shaping patients' perceptions of their bowel health within the SCI population. In addition to the more expected determinants of bowel-related QoL, such as the severity of bowel dysfunction, resilience emerged as a notable factor. Accordingly, integrating interventions that enhance resilience within bowel rehabilitation programs may yield improvements in patients' perceived bowel health beyond the benefits achievable through bowel function enhancement alone.
- Open Access
- 11 May 2023
- Published by Wiley in Neurourology and Urodynamics
- Vol. 42 (6) , 1362-1373
Content, face, and construct validity of the Irritable Bowel Syndrome Quality of Life (IBS‐QOL) as a measure of bowel‐related quality of life in spinal cord injury
Introduction: Neurogenic bowel dysfunction is commonly encountered after a spinal cord injury (SCI), leading to a tremendous impact on quality of life (QOL). The neurogenic bowel dysfunction score (NBDS) is commonly used to measure the severity of bowel dysfunction and predict QOL. However, there is no comprehensive instrument to assess bowel‐specific QOL for SCI patients. Instead, the Irritable Bowel Syndrome‐Quality of Life (IBS‐QOL) questionnaire evaluates the impact of bowel dysfunction on several aspects of QOL, although this questionnaire has not been validated for the SCI population. Motivated by the compelling need of instruments to accurately evaluate the QOL in patients who develope NBD after SCI, we aimed to assess the construct, content, and face validity of IBS‐QOL in this population.Methods: Adult SCI patients with at least 3 months after their injury were recruited from the outpatient clinic of a national rehabilitation hospital. Patients completed the NBDS and IBS‐QOL via telephone interview or paper survey in the clinic. Content and face validity were assessed via interviews with professionals with expertise in providing chronic care for SCI, as well as a subgroup of patients. Construct validity was assessed using the hypotheses testing method. Internal consistency was assessed using Cronbach's ⍺. Factor analysis was performed to assess the dimensionality of the IBS‐QOL in the SCI population.Results: A total of 106 patients with a median age of 45.5 years (interquartile range: 21–79) participated in the study. The majority of the sample were men (n = 82, 77%) and had endured thoracolumbar injuries (n = 74, 71.2%). Twelve patients (seven English‐ and five Spanish speakers) and six professionals took part in content/face validation interviews. The median IBS‐QOL total score was 15.91/100 (interquartile range: 4.55–33.14). IBS‐QOL differentiated the subgroups of patients with severe bowel symptoms in terms of uneasiness, sweating, or headaches during bowel emptying (p = 0.0003), time spent on bowel emptying (p = 0.0065), flatus incontinence (p = 0.0076), and overall satisfaction with bowel function (p < 0.001), demonstrating its adequate construct validity. Interviews with the patients and professionals supported the comprehensiveness, comprehensibility, and relevance of IBS‐QOL for assessment of bowel‐related QOL in the SCI population. Item‐level analysis of professional responses showed that 97% of questions were relevant to the construct and population of interest. Internal consistency analysis yielded a Cronbach's ⍺ of 0.9684. Exploratory factor analysis yielded six underlying factors which cumulatively accounted for 72.21% of the total variance, reflecting the dimensionality of bowel‐related QOL in SCI population.Discussion: IBS‐QOL questionnaire is a comprehensive measure of bowel‐related QOL which encompasses the concerns of SCI patients. Our findings support the content, face and construct validity of IBS‐QOL as a measure of bowel‐related QOL in SCI. Further studies are warranted to assess the reliability and responsiveness of IBS‐QOL, and to evaluate its performance across different patient populations.
- 11 May 2023
- Published by Wiley in Neurourology and Urodynamics
- Vol. 42 (6) , 1362-1373
Open AccessContent, face, and construct validity of the Irritable Bowel Syndrome Quality of Life (IBS‐QOL) as a measure of bowel‐related quality of life in spinal cord injury
Introduction: Neurogenic bowel dysfunction is commonly encountered after a spinal cord injury (SCI), leading to a tremendous impact on quality of life (QOL). The neurogenic bowel dysfunction score (NBDS) is commonly used to measure the severity of bowel dysfunction and predict QOL. However, there is no comprehensive instrument to assess bowel‐specific QOL for SCI patients. Instead, the Irritable Bowel Syndrome‐Quality of Life (IBS‐QOL) questionnaire evaluates the impact of bowel dysfunction on several aspects of QOL, although this questionnaire has not been validated for the SCI population. Motivated by the compelling need of instruments to accurately evaluate the QOL in patients who develope NBD after SCI, we aimed to assess the construct, content, and face validity of IBS‐QOL in this population.Methods: Adult SCI patients with at least 3 months after their injury were recruited from the outpatient clinic of a national rehabilitation hospital. Patients completed the NBDS and IBS‐QOL via telephone interview or paper survey in the clinic. Content and face validity were assessed via interviews with professionals with expertise in providing chronic care for SCI, as well as a subgroup of patients. Construct validity was assessed using the hypotheses testing method. Internal consistency was assessed using Cronbach's ⍺. Factor analysis was performed to assess the dimensionality of the IBS‐QOL in the SCI population.Results: A total of 106 patients with a median age of 45.5 years (interquartile range: 21–79) participated in the study. The majority of the sample were men (n = 82, 77%) and had endured thoracolumbar injuries (n = 74, 71.2%). Twelve patients (seven English‐ and five Spanish speakers) and six professionals took part in content/face validation interviews. The median IBS‐QOL total score was 15.91/100 (interquartile range: 4.55–33.14). IBS‐QOL differentiated the subgroups of patients with severe bowel symptoms in terms of uneasiness, sweating, or headaches during bowel emptying (p = 0.0003), time spent on bowel emptying (p = 0.0065), flatus incontinence (p = 0.0076), and overall satisfaction with bowel function (p < 0.001), demonstrating its adequate construct validity. Interviews with the patients and professionals supported the comprehensiveness, comprehensibility, and relevance of IBS‐QOL for assessment of bowel‐related QOL in the SCI population. Item‐level analysis of professional responses showed that 97% of questions were relevant to the construct and population of interest. Internal consistency analysis yielded a Cronbach's ⍺ of 0.9684. Exploratory factor analysis yielded six underlying factors which cumulatively accounted for 72.21% of the total variance, reflecting the dimensionality of bowel‐related QOL in SCI population.Discussion: IBS‐QOL questionnaire is a comprehensive measure of bowel‐related QOL which encompasses the concerns of SCI patients. Our findings support the content, face and construct validity of IBS‐QOL as a measure of bowel‐related QOL in SCI. Further studies are warranted to assess the reliability and responsiveness of IBS‐QOL, and to evaluate its performance across different patient populations.